Annual report pursuant to Section 13 and 15(d)

Going Concern (Details Narrative)

v3.21.2
Going Concern (Details Narrative) - USD ($)
12 Months Ended
Jan. 28, 2021
Apr. 30, 2021
Apr. 30, 2020
Feb. 02, 2021
Apr. 02, 2020
Cash   $ 13,645,405 $ 2,749,957    
Working capital   13,500,000      
Accumulated deficit   (43,975,046) (31,587,952)    
Net loss   (12,387,094) (5,249,350)    
Cash used in operating activities   $ (8,590,636) $ (3,897,743)    
Number of warrats issued         357,142
Exercise price of warrants         $ 7.00
Purchase Agreement [Member]          
Exercise price of warrants       $ 14.50  
Purchase Agreement [Member] | Accredited Investors [Member]          
Number of common stock issued for sale 914,136        
Common stock at per share $ 10.54        
Proceeds from sale of equity $ 9,600,000        
Purchase Agreement [Member] | Accredited Investors [Member] | Private Placement [Member]          
Number of warrats issued 457,068        
Exercise price of warrants $ 14.50